World's Best Scientists 2026 revealed!
Klaus Pfizenmaier

Klaus Pfizenmaier

D-Index & Metrics

Biology and Biochemistry

D-Index
86
Citations
25920
World Ranking
2973
National Ranking
220

Klaus Pfizenmaier publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Klaus Pfizenmaier sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 263 publications — 71st percentile

71% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Klaus Pfizenmaier D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Klaus Pfizenmaier sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 86 D-Index — 85th percentile

85% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Klaus Pfizenmaier is affiliated with the University of Stuttgart in Germany and focuses their research primarily on medicine and immunology and microbiology. Their work spans multiple subfields including immunology, oncology, pathology and forensic medicine, neurology, and radiology, nuclear medicine and imaging.

Their research topics cover a range of areas within immunology and neurological disease, notably:

  • Multiple Sclerosis Research Studies
  • Cytokine Signaling Pathways and Interactions
  • Immune Response and Inflammation
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Monoclonal and Polyclonal Antibodies Research
  • Peptidase Inhibition and Analysis
  • Immunotherapy and Immune Responses

Pfizenmaier has authored several papers published across multiple journals. Recent articles include:

  • "Selective Targeting of TNF Receptors as a Novel Therapeutic Approach," 2020, Frontiers in Cell and Developmental Biology
  • "TNF-Receptor-1 inhibition reduces liver steatosis, hepatocellular injury and fibrosis in NAFLD mice," 2020, Cell Death and Disease
  • "OMTX705, a Novel FAP-Targeting ADC Demonstrates Activity in Chemotherapy and Pembrolizumab-Resistant Solid Tumor Models," 2020, Clinical Cancer Research
  • "The TNFR1 Antagonist Atrosimab Is Therapeutic in Mouse Models of Acute and Chronic Inflammation," 2021, Frontiers in Immunology
  • "Co-modulation of TNFR1 and TNFR2 in an animal model of multiple sclerosis," 2023, Journal of Neuroinflammation

Their publications have appeared frequently in venues such as:

  • Journal of Neuroinflammation
  • Scientific Reports
  • Cancer Research
  • Frontiers in Cell and Developmental Biology
  • Cell Death and Disease

Pfizenmaier collaborates regularly with several researchers, with numerous co-authored works involving:

  • Roland E. Kontermann
  • Roman Fischer
  • Cristina Suárez Ferrer
  • Oliver Seifert
  • Fabian Richter

Best Publications

  • Tumor necrosis factor signaling.

    H Wajant;K Pfizenmaier;P Scheurich

  • THE TRANSMEMBRANE FORM OF TUMOR NECROSIS FACTOR IS THE PRIME ACTIVATING LIGAND OF THE 80 KDA TUMOR NECROSIS FACTOR RECEPTOR

    Matthias Grell;Eleni Douni;Harald Wajant;Matthias Löhden

  • PKCu is a novel, atypical member of the protein kinase C family.

    F.J. Johannes;J. Prestle;S. Eis;P. Oberhagemann

  • PKC zeta is a molecular switch in signal transduction of TNF-alpha, bifunctionally regulated by ceramide and arachidonic acid.

    Gertraud Müller;Mohamed Ayoub;Peter Storz;Jörg Rennecke

  • Immunoregulatory activity of recombinant human tumor necrosis factor (TNF)-alpha: induction of TNF receptors on human T cells and TNF-alpha-mediated enhancement of T cell responses

    P Scheurich;B Thoma;U Ucer;K Pfizenmaier

  • Tumor necrosis factor (TNF)-mediated neuroprotection against glutamate-induced excitotoxicity is enhanced by N-methyl-D-aspartate receptor activation. Essential role of a TNF receptor 2-mediated phosphatidylinositol 3-kinase-dependent NF-kappa B pathway.

    Lara Marchetti;Matthias Klein;Katalin Schlett;Katalin Schlett;Klaus Pfizenmaier

  • Neurodegenerative and neuroprotective effects of tumor Necrosis factor (TNF) in retinal ischemia: opposite roles of TNF receptor 1 and TNF receptor 2.

    Valerie Fontaine;Saddek Mohand-Said;Noelle Hanoteau;Céline Fuchs

  • Cyclophosphamide-sensitive T lymphocytes suppress the in vivo generation of antigen-specific cytotoxic T lymphocytes

    M Rollinghoff;A Starzinski-Powitz;K Pfizenmaier;H Wagner

  • Protein kinase D regulates vesicular transport by phosphorylating and activating phosphatidylinositol-4 kinase IIIβ at the Golgi complex

    Angelika Hausser;Peter Storz;Susanne Märtens;Gisela Link

  • Antitumor Effects of Chimeric Receptor Engineered Human T Cells Directed to Tumor Stroma

    Sunitha Kakarla;Kevin K H Chow;Kevin K H Chow;Melinda Mata;Melinda Mata;Donald R Shaffer;Donald R Shaffer

  • Tumor necrosis factor enhances HLA-A,B,C and HLA-DR gene expression in human tumor cells.

    K Pfizenmaier;P Scheurich;C Schlüter;M Krönke

  • T-T cell interactions during cytotoxic T lymphocyte (CTL) responses: T cell derived helper factor (Interleukin 2) as a probe to analyze CTL responsiveness and thymic maturation of CTL progenitors.

    Hermann Wagner;Conny Hardt;Klaus Heeg;Klaus Pfizenmaier

  • T-cell-derived helper factor allows in vivo induction of cytotoxic T cells in nu/nu mice.

    Hermann Wagner;Conny Hardt;Klaus Heeg;Martin Röllinghoff

  • Peyer's patch organogenesis is intact yet formation of B lymphocyte follicles is defective in peripheral lymphoid organs of mice deficient for tumor necrosis factor and its 55-kDa receptor.

    Manolis Pasparakis;Lena Alexopoulou;Matthias Grell;Klaus Pfizenmaier

  • Non-apoptotic Fas signaling.

    Harald Wajant;Klaus Pfizenmaier;Peter Scheurich

  • Differential activation of TRAIL-R1 and -2 by soluble and membrane TRAIL allows selective surface antigen-directed activation of TRAIL-R2 by a soluble TRAIL derivative.

    Harald Wajant;Dieter Moosmayer;Dieter Moosmayer;Thomas Wüest;Till Bartke

  • Molecular cloning and expression of human and rat tumor necrosis factor receptor chain (p60) and its soluble derivative, tumor necrosis factor-binding protein.

    Adolf Himmler;Ingrid Maurer-Fogy;Martin Krönke;Peter Scheurich

  • Trimer Stabilization, Oligomerization, and Antibody-Mediated Cell Surface Immobilization Improve the Activity of Soluble Trimers of CD27L, CD40L, 41BBL, and Glucocorticoid-Induced TNF Receptor Ligand

    Agnes Wyzgol;Nicole Müller;Andrea Fick;Sabine Munkel

  • Regulation of secretory transport by protein kinase D–mediated phosphorylation of the ceramide transfer protein

    Tim Fugmann;Angelika Hausser;Patrik Schöffler;Simone Schmid

  • In vivo evidence for a functional role of both tumor necrosis factor (TNF) receptors and transmembrane TNF in experimental hepatitis.

    Sabine Küsters;Gisa Tiegs;Lena Alexopoulou;Manolis Pasparakis

Frequent Co-Authors

Roland E. Kontermann
Roland E. Kontermann University of Stuttgart
Harald Wajant
Harald Wajant University of Würzburg
Peter Scheurich
Peter Scheurich University of Stuttgart
Martin Röllinghoff
Martin Röllinghoff University of Erlangen-Nuremberg
Hermann Wagner
Hermann Wagner Technical University of Munich
Martin Krönke
Martin Krönke University of Cologne
John R. Bethea
John R. Bethea George Washington University
Andreas Herrmann
Andreas Herrmann Humboldt-Universität zu Berlin
Stephen Gottschalk
Stephen Gottschalk St. Jude Children's Research Hospital
George Kollias
George Kollias National and Kapodistrian University of Athens

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Klaus Pfizenmaier

Trending Scientists

Recently Published Articles